Dallas, Texas
Phase 1 cancer trials in Dallas, TX
100 Phase 1 cancer studies are recruiting participants at sites in Dallas as of November 17, 2026, according to ClinicalTrials.gov. Phase 1 Cancer Trials can help you understand your options and connect with a study team.
- No cost to ask
- Taking part is voluntary
- Studies are independently reviewed
Dallas at a glance
- 100 studies are recruiting at a site in Dallas.
- By phase: Early Phase 1 (3), Phase 1 (51), Phase 1/2 (46).
- By sponsor: industry (89), university, hospital or other (11).
- By research area: Breast Cancer (34), Lung Cancer (31), Lymphoma (19), Prostate Cancer (8), Melanoma (4), Pancreatic Cancer (4).
- Most recent update to one of these records: November 17, 2026.
Breast cancer studies recruiting in Dallas
Basic details from each study's public record (the 30 most recently updated of 100). Select a study to read the full record on ClinicalTrials.gov, including how to contact its team.
A Phase 1/2 Study of IAM1363 in HER2 Cancers
- Phase 1/2
- Ages 18 and older
- All sexes
- Sponsor
- Iambic Therapeutics, Inc
- Study site
- Mary Crowley Cancer Research
- Registry record
- NCT06253871 · updated
A First-in-Human Study of MEN2312 in Adults With Advanced Breast Cancer
- Phase 1
- Ages 18 and older
- All sexes
- Sponsor
- Stemline Therapeutics, Inc.
- Study site
- University of Texas Southwestern Medical Center
- Registry record
- NCT06638307 · updated
A Clinical Study to Find the Optimal Dose of an Investigational Treatment Called BNT323 When Used in Combination With Another Investigational Treatment, BNT327, and to Test if That Combination Treatment is Safe and Beneficial for Patients With Advanced Breast Cancer
- Phase 1/2
- Ages 18 and older
- All sexes
- Sponsor
- BioNTech SE
- Study sites
- Baylor Scott & White Research Institute -Texas Oncology · UT Southwestern Medical Center
- Registry record
- NCT06827236 · updated
A Study With NKT3964 for Adults With Advanced/Metastatic Solid Tumors
- Phase 1
- Ages 19 and older
- All sexes
- Sponsor
- NiKang Therapeutics, Inc.
- Study site
- UT Southwestern
- Registry record
- NCT06586957 · updated
A Study With NKT5097 for Adults With Advanced/Metastatic Solid Tumors
- Phase 1
- Ages 18 and older
- All sexes
- Sponsor
- NiKang Therapeutics, Inc.
- Study site
- University of Texas Southwestern Medical Center
- Registry record
- NCT07029399 · updated
Rinatabart Sesutecan (Rina-S, PRO1184, GEN1184) for Advanced Solid Tumors (GCT1184-01/ PRO1184-001)
- Phase 1/2
- Ages 18 and older
- All sexes
- Sponsor
- Genmab
- Study site
- Mary Crowley Cancer Research
- Registry record
- NCT05579366 · updated
A Study of LY4337713 in Participants With FAP-Positive Solid Tumors
- Phase 1
- Ages 18 and older
- All sexes
- Sponsor
- Eli Lilly and Company
- Study site
- Texas Oncology - DFW (Sammons CC)
- Registry record
- NCT07213791 · updated
Study of IEV407 as Single Agent or in Combination in Patients With Advanced HR+/HER2- Breast Cancer
- Phase 1
- Ages 18 and older
- All sexes
- Sponsor
- Novartis Pharmaceuticals
- Study site
- Mary Crowley Cancer Research
- Registry record
- NCT07604571 · updated
Study of XB010 in Subjects With Solid Tumors
- Phase 1
- Ages 18 and older
- All sexes
- Sponsor
- Exelixis
- Study site
- Baylor University Medical Center
- Registry record
- NCT06545331 · updated
[18F]FPyQCP PET Imaging of Fibroblast Activation Protein in Selected Oncology Indications
- Phase 1/2
- Ages 18 to 80
- All sexes
- Sponsor
- Blue Earth Diagnostics
- Study site
- University of Texas Southwestern Medical Center
- Registry record
- NCT07432633 · updated
A Study to Evaluate the Efficacy and Safety of Ifinatamab Deruxtecan (I-DXd) in Subjects With Recurrent or Metastatic Solid Tumors (IDeate-PanTumor02)
- Phase 1/2
- Ages 18 and older
- All sexes
- Sponsor
- Daiichi Sankyo
- Study site
- Texas Oncology, P.A.
- Registry record
- NCT06330064 · updated
A Study to Evaluate the Effect of GDC-4198 Alone and in Combination With Giredestrant Versus Abemaciclib and Giredestrant in Participants With Locally Advanced or Metastatic Estrogen Receptor-Positive (ER+), Human Epidermal Growth Factor Receptor-Negative (HER2-) Breast Cancer
- Phase 1/2
- Ages 18 and older
- All sexes
- Sponsor
- Genentech, Inc.
- Study site
- Texas Oncology (Worth) - USOR
- Registry record
- NCT07100106 · updated
Source: ClinicalTrials.gov. Data processed . See every breast cancer study recruiting in Dallas, TX on ClinicalTrials.gov.
Lung cancer studies recruiting in Dallas
A Study of VET3-TGI in Patients With Solid Tumors
- Phase 1
- Ages 18 and older
- All sexes
- Sponsor
- KaliVir Immunotherapeutics
- Study site
- Mary Crowley Cancer Research/Sarah Cannon Research Institute
- Registry record
- NCT06444815 · updated
Beamion LUNG-1: A Study to Test Different Doses of Zongertinib in People With Different Types of Advanced Cancer (Solid Tumours With Changes in the HER2 Gene)
- Phase 1
- Ages 18 and older
- All sexes
- Sponsor
- Boehringer Ingelheim
- Study site
- Mary Crowley Cancer Research Center
- Registry record
- NCT04886804 · updated
Evaluating BL-M14D1 in Subjects With Locally Advanced or Metastatic Small Cell Lung Cancer and Neuroendocrine Tumors
- Phase 1
- Ages 18 and older
- All sexes
- Sponsor
- SystImmune Inc.
- Study sites
- NEXT Dallas · START Dallas- Fort Worth
- Registry record
- NCT07080242 · updated
SI-B036-ST-101 in Advanced/Metastatic Solid Tumors
- Phase 1
- Ages 18 and older
- All sexes
- Sponsor
- SystImmune Inc.
- Study site
- Mary Crowley Cancer Research
- Registry record
- NCT07857616 · updated
Phase 1 Study Evaluating the Safety and PK of ADU-1805 in Advanced Solid Tumors
- Phase 1
- Ages 18 and older
- All sexes
- Sponsor
- Sairopa B.V.
- Study site
- University of Texas Southwestern Medical Center
- Registry record
- NCT05856981 · updated
A Study to Investigate the Safety and Efficacy of KQB368 as Monotherapy in Participants With Advanced Solid Malignancies
- Phase 1
- Ages 18 and older
- All sexes
- Sponsor
- Kumquat Biosciences Inc.
- Study site
- START Dallas Fort Worth
- Registry record
- NCT07542704 · updated
CR-002 in Adult Participants With Locally Advanced or Metastatic Solid Tumors
- Phase 1/2
- Ages 18 and older
- All sexes
- Sponsor
- Crescent Biopharma, Inc.
- Registry record
- NCT07909031 · updated
SW-682 in Advanced Solid Tumors
- Phase 1
- Ages 18 and older
- All sexes
- Sponsor
- SpringWorks Therapeutics, Inc., a healthcare company of Merck KGaA, Darmstadt, Germany
- Study site
- Mary Crowley Research Center US Oncology
- Registry record
- NCT06251310 · updated
A Study of Gilteritinib in Adults With Advanced ALK-positive Non-small Cell Lung Cancer (NSCLC)
- Phase 1
- Ages 18 and older
- All sexes
- Sponsor
- Astellas Pharma Global Development, Inc.
- Study site
- UT Southwestern Medical Center at Dallas
- Registry record
- NCT07140016 · updated
Source: ClinicalTrials.gov. Data processed . See every lung cancer study recruiting in Dallas, TX on ClinicalTrials.gov.
Prostate cancer studies recruiting in Dallas
Study of JANX007 in Subjects With Metastatic Castration-Resistant Prostate Cancer (ENGAGER-PSMA-01)
- Phase 1
- Ages 18 to 100
- Male participants
- Sponsor
- Janux Therapeutics
- Study sites
- Mary Crowley Cancer Research · University of Texas Southwestern Medical Center
- Registry record
- NCT05519449 · updated
A Study to Investigate the Safety and Tolerability of Oral INR731 Single Agent or in Combination With Androgen Receptor Pathway Inhibitor (ARPI) in Patients With Metastatic Prostate Cancer
- Phase 1
- Ages 18 and older
- Male participants
- Sponsor
- Novartis Pharmaceuticals
- Study site
- Mary Crowley Cancer Research
- Registry record
- NCT07570979 · updated
Source: ClinicalTrials.gov. Data processed . See every prostate cancer study recruiting in Dallas, TX on ClinicalTrials.gov.
Melanoma studies recruiting in Dallas
A Study of Pembrolizumab (MK-3475) in Pediatric Participants With an Advanced Solid Tumor or Lymphoma (MK-3475-051/KEYNOTE-051)
- Phase 1/2
- From 6 months, up to 17 years
- All sexes
- Sponsor
- Merck Sharp & Dohme LLC
- Study site
- Call for Information (Investigational Site 0054)
- Registry record
- NCT02332668 · updated
Source: ClinicalTrials.gov. Data processed . See every melanoma study recruiting in Dallas, TX on ClinicalTrials.gov.
Lymphoma studies recruiting in Dallas
The Pediatric Acute Leukemia (PedAL) Screening Trial - A Study to Test Bone Marrow and Blood in Children With Leukemia That Has Come Back After Treatment or Is Difficult to Treat - A Leukemia & Lymphoma Society and Children's Oncology Group Study
- Phase 1/2
- Up to age 22
- All sexes
- Sponsor
- PedAL BCU, LLC
- Study sites
- Medical City Dallas Hospital · UT Southwestern/Simmons Cancer Center-Dallas
- Registry record
- NCT04726241 · updated
A Study of Zedoresertib (Debio 0123) in Combination With Temozolomide in Adult Participants With Recurrent or Progressive Glioblastoma and of Zedoresertib (Debio 0123) in Combination With Temozolomide and Radiotherapy in Adult Participants With Newly Diagnosed Glioblastoma
- Phase 1/2
- Ages 18 and older
- All sexes
- Sponsor
- Debiopharm International SA
- Study site
- Baylor Scott & White Research Institute
- Registry record
- NCT05765812 · updated
A Study of LY4152199 in Participants With Previously Treated B-cell Malignancies (BAF_FRontier-1 )
- Phase 1
- Ages 18 and older
- All sexes
- Sponsor
- Eli Lilly and Company
- Study site
- University of Texas Southwestern
- Registry record
- NCT07101328 · updated
A Study of LY4584180 in Adult Participants With Previously Treated Blood Cancers
- Phase 1
- Ages 18 and older
- All sexes
- Sponsor
- Eli Lilly and Company
- Study site
- Texas Oncology - DFW (Sammons CC)
- Registry record
- NCT07226843 · updated
Source: ClinicalTrials.gov. Data processed . See every lymphoma study recruiting in Dallas, TX on ClinicalTrials.gov.
Pancreatic cancer studies recruiting in Dallas
Lead-212 PSV359 Therapy for Patients With Solid Tumors
- Phase 1/2
- Ages 18 to 90
- All sexes
- Sponsor
- Perspective Therapeutics
- Study site
- UT Southwestern University Hospital Radiology Clinic
- Registry record
- NCT06710756 · updated
A Study of ART0380 for the Treatment of Advanced or Metastatic Solid Tumors
- Phase 1/2
- Ages 18 and older
- All sexes
- Sponsor
- Artios Pharma Ltd
- Study sites
- Mary Crowley Cancer Research · University of Texas Southwestern
- Registry record
- NCT04657068 · updated
Source: ClinicalTrials.gov. Data processed . See every pancreatic cancer study recruiting in Dallas, TX on ClinicalTrials.gov.
Ask about studies near Dallas
Tell us what you are looking for and a coordinator will contact you to talk through your options. Asking does not commit you to anything.
Before you contact a study
How taking part works
From your first question to your decision: what happens and who you talk to along the way.
Questions to ask a study team
What to ask about time, risks and your rights before you agree to anything.
Eligibility and screening
How a study team works out whether a study is suitable for you.
More locations in Texas
All Texas locations
406 studies recruiting across 29 cities.
Houston
276 studies recruiting.
San Antonio
118 studies recruiting.
About these listings
These listings come from ClinicalTrials.gov, the study registry run by the U.S. National Library of Medicine. The data were processed on November 17, 2026. We show part of each public record (its title, phase, sponsor, basic eligibility and sites in this area) exactly as registered, and we group studies by place. Nothing in a record is reworded. This site lists only studies that are in Phase 1, including early Phase 1 and combined Phase 1/2, as each study is coded in the registry.
Phase 1 Cancer Trials does not run these studies and is not affiliated with their sponsors. A listing is not a recommendation, and only a study's own team can tell you whether you may be eligible. Follow the link on any study to read its full record and contact that team directly, or ask us and a coordinator will help you understand your options. How we source and check what we publish.
Sources and further reading
- ClinicalTrials.gov study registry — ClinicalTrials.gov (National Library of Medicine)
- Terms and Conditions for use of ClinicalTrials.gov data — ClinicalTrials.gov (National Library of Medicine)
- Questions to Ask About Volunteering for a Research Study — HHS Office for Human Research Protections